Sujun Gao Selected Research

Sujun Gao Research Topics

Disease

12	Neoplasms (Cancer) 09/2023 - 07/2013
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2023 - 01/2014
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2023 - 01/2020
5	Leukemia 07/2023 - 01/2014
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 11/2020
4	Infections 01/2024 - 01/2017
4	Hematologic Neoplasms (Hematological Malignancy) 12/2023 - 07/2013
4	Multiple Myeloma 10/2023 - 06/2014
4	Aplastic Anemia (Anemia, Hypoplastic) 12/2022 - 06/2020
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2022 - 09/2013
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2022 - 11/2016
3	Hemorrhage 01/2022 - 01/2020
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2024 - 08/2019
2	Disease Progression 12/2023 - 12/2023
2	Lymphoma (Lymphomas) 11/2023 - 01/2023
2	Primary Myelofibrosis (Myelosclerosis) 10/2023 - 10/2023
2	Iron Overload 01/2023 - 12/2022
2	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 01/2021
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 01/2021
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 01/2021
2	Acute Promyelocytic Leukemia 10/2020 - 06/2004
2	Residual Neoplasm 12/2019 - 01/2018
2	Neoplasm Metastasis (Metastasis) 02/2019 - 01/2014
2	Adenocarcinoma 01/2014 - 07/2013
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 12/2023
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 12/2023
1	Splenomegaly 10/2023
1	Hyperplasia 10/2023
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2023
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023
1	Lymphocytosis 01/2023
1	Philadelphia Chromosome 12/2022
1	Rhizomucor pusillus infection 03/2022
1	Mucormycosis 03/2022
1	Neutropenia 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2021
1	Ulcerative Colitis 08/2021
1	Invasive Fungal Infections 07/2021
1	Aspergillosis 07/2021
1	Mycoses (Diseases, Fungus) 07/2021
1	Seizures (Absence Seizure) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Hematuria 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2020
1	Systemic Vasculitis 11/2020
1	Liver Cell Adenoma (Hepatocellular Adenoma) 07/2020

Drug/Important Bio-Agent (IBA)

8	zanubrutinibIBA 09/2023 - 01/2020
4	hetrombopagIBA 12/2022 - 01/2021
4	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 01/2020
3	orelabrutinibIBA 11/2023 - 01/2023
3	Decitabine FDA Link 11/2020 - 12/2019
3	Interleukin-33IBA 01/2019 - 01/2018
2	Tyrosine Kinase InhibitorsIBA 01/2024 - 12/2023
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023 - 01/2022
2	Janus Kinase InhibitorsIBA 10/2023 - 10/2023
2	ruxolitinibIBA 10/2023 - 10/2023
2	Thrombopoietin (c-mpl Ligand)IBA 12/2022 - 01/2022
2	posaconazole FDA Link 03/2022 - 07/2021
2	Inosine Triphosphate (ITP)IBA 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2014
2	CytokinesIBA 01/2020 - 11/2016
2	Indicators and Reagents (Reagents)IBA 12/2019 - 01/2014
2	Mucin-1 (CA 15-3 Antigen)IBA 01/2016 - 07/2013
1	ibrutinibIBA 12/2023
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2023
1	Thalidomide (Thalomid)FDA Link 10/2023
1	CollagenIBA 10/2023
1	NucleophosminIBA 07/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Complement Inactivating AgentsIBA 01/2023
1	Prostaglandins FIBA 12/2022
1	IronIBA 12/2022
1	blinatumomabIBA 12/2022
1	SilverIBA 03/2022
1	Cell-Free Nucleic AcidsIBA 03/2022
1	Liposomes (Liposome)IBA 03/2022
1	Amphotericin B (Amphotericin)FDA LinkGeneric 03/2022
1	Proteasome InhibitorsIBA 01/2022
1	selinexorIBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	CTLA-4 AntigenIBA 12/2021
1	artenimol (dihydroartemisinin)IBA 08/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2021
1	Thrombopoietin ReceptorsIBA 01/2021
1	nuclear pore complex protein 98IBA 10/2020
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 10/2020
1	AlkaloidsIBA 10/2020
1	Anabolic Androgenic SteroidsIBA 07/2020
1	SteroidsIBA 07/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2020
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 06/2020

Therapy/Procedure

12	Therapeutics 12/2023 - 01/2014
8	Hematopoietic Stem Cell Transplantation 01/2024 - 01/2017
5	Immunotherapy 09/2023 - 07/2013
3	Drug Therapy (Chemotherapy) 07/2021 - 01/2018
1	Drug Tapering 01/2022
1	Salvage Therapy 07/2021
1	Transplantation 01/2021